Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer purchases of equity securities for the three months ended March 31, 2024 were as follows:
ISSUER PURCHASES OF EQUITY SECURITIES
($ in millions)
Period Total Number
of Shares
Purchased (1)
Average Price
Paid Per
Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares
That May Yet Be Purchased
Under the Plans or Programs (1)
January 1 - January 31
147,500 $112.29 147,500 $3,684
February 1 - February 29
209,200 $127.83 209,200 $3,658
March 1 - March 31
633,971 $123.45 633,971 $3,579
Total 990,671 $122.71 990,671
(1) Shares purchased during the period were made as part of a plan approved by the Board of Directors in October 2018 to purchase up to $10 billion of Merck’s common stock for its treasury.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.